Galvanize Therapeutics
Focus: Galvanize Therapeutics is a public biotechnology company focused on bronchoscopic delivery of non-thermal pulsed electric fields (PEF) for oncology applications, particularly lung cancer. The company operates at 5,000+ employees with headquarters in San Carlos, CA.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
5000+
Open Jobs
0
About Galvanize Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Galvanize Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Pulsed electric field treatment using the Aliya system
Cancer of Lung, Kidney or LiverClinical Trials (1)
NCT04773275A Clinical Evaluation of the Aliya™ System in Late Stage Cancer
N/AHelp build intelligence for Galvanize Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.